BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 30208594)

  • 1. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?
    Yamaguchi J; Tanaka T; Inagi R
    Nephron; 2017; 135(3):201-206. PubMed ID: 27960172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate.
    Opdebeeck B; D'Haese PC; Verhulst A
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
    Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the efficacy of AST-120 (KREMEZIN
    Asai M; Kumakura S; Kikuchi M
    Ren Fail; 2019 Nov; 41(1):47-56. PubMed ID: 30732506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of carbon adsorbent in the conservative management of chronic kidney disease.
    Niwa T
    Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.
    Gryp T; Huys GRB; Joossens M; Van Biesen W; Glorieux G; Vaneechoutte M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating
    Chang JF; Hsieh CY; Liou JC; Lu KC; Zheng CM; Wu MS; Chang SW; Wang TM; Wu CC
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CharXgen-Activated Bamboo Charcoal Encapsulated in Sodium Alginate Microsphere as the Absorbent of Uremic Toxins to Retard Kidney Function Deterioration.
    Lin CJ; Sun CY; Wu CJ; Wu CC; Wu V; Lin FH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.
    Yamamoto S; Kazama JJ; Omori K; Matsuo K; Takahashi Y; Kawamura K; Matsuto T; Watanabe H; Maruyama T; Narita I
    Sci Rep; 2015 Sep; 5():14381. PubMed ID: 26395517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
    Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
    Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin enhances p-cresyl sulfate-induced cytotoxic effects on renal tubular cells.
    Wei CW; Wu TK; Wu SC; Chen YL; Pan YR; Chien YC; Wu JY; Yu YL; Yiang GT
    Int J Med Sci; 2022; 19(7):1138-1146. PubMed ID: 35919818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.